menu
    • menu

    Company profile for InDex Pharmaceuticals

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Despite the currently available drug treatment alternatives, a substantial group of patients with ulcerative colitis suffer from difficult symptoms such as pain and frequent, bloody diarrhea. InDex Pharmaceuticals lead drug candidate is cobitolimod – a new type of drug that can help patients back to a normal life. InDex has also developed a platform of patent protected substances, so called DNA based ImmunoModulatory Seq...
    Despite the currently available drug treatment alternatives, a substantial group of patients with ulcerative colitis suffer from difficult symptoms such as pain and frequent, bloody diarrhea. InDex Pharmaceuticals lead drug candidate is cobitolimod – a new type of drug that can help patients back to a normal life. InDex has also developed a platform of patent protected substances, so called DNA based ImmunoModulatory Sequences (DIMS), with the potential to be used in treatment of various immunological diseases. The company is based at the Karolinska Institutet Science Park in Stockholm.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    InDex PharmaceuticalsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    InDex Pharmaceuticals Holding AB (publ) Tomtebodavägen 23a SE-171 77 Stockhol...
    Telephone
    Telephone
    +46 8 508 847 30
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.indexpharma.com/en/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    InDex Pharmaceuticals announces expected cash balance per March 31, 2024
    InDex Pharmaceuticals announces expected cash balance per March 31, 2024

    19 Jan 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-expected-cash-balance-per-march-31-2024-302039363.html

    PR NEWSWIRE
    19 Jan 2024
    Share Share
    InDex Pharmaceuticals discontinues cobitolimod phase III program
    InDex Pharmaceuticals discontinues cobitolimod phase III program

    22 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/index-pharmaceuticals-discontinues-cobitolimod-phase-iii-program-301995261.html

    PR NEWSWIRE
    22 Nov 2023
    Share Share
    InDex Pharma has been granted a new patent for cobitolimod in South Korea
    InDex Pharma has been granted a new patent for cobitolimod in South Korea

    20 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/index-pharmaceuticals-has-been-granted-a-new-patent-for-cobitolimod-in-south-korea-301963166.html

    PR NEWSWIRE
    20 Oct 2023
    Share Share
    InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE
    InDex Pharmaceuticals announces that all patients needed for the cobitolimod dose selection milestone have completed Induction Study 1 of the phase III program CONCLUDE

    11 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/index-pharmaceuticals-announces-that-all-patients-needed-for-the-cobitolimod-dose-selection-milestone-have-completed-induction-study-1-of-the-phase-iii-program-conclude-301953209.html

    PR NEWSWIRE
    11 Oct 2023
    Share Share
    InDex Pharmaceuticals is attending the UEGW 2023 congress
    InDex Pharmaceuticals is attending the UEGW 2023 congress

    05 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/index-pharmaceuticals-is-attending-the-uegw-2023-congress-301948229.html

    PR NEWSWIRE
    05 Oct 2023
    Share Share
    Positive results from PK study with cobitolimod' selected as one of the best abstracts for presentation
    Positive results from PK study with cobitolimod' selected as one of the best abstracts for presentation

    22 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/positive-results-from-pk-study-with-cobitolimod-selected-as-one-of-the-best-abstracts-for-poster-presentation-at-uegw-index-pharmaceuticals-301906507.html

    PR NEWSWIRE
    22 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search